Funding for this research was provided by:
University of Massachusetts Medical School (No award number)
Received: 25 January 2020
Accepted: 12 June 2020
First Online: 21 July 2020
Ethics approval and consent to participate
: The study was approved by the University of Massachusetts Medical School-Baystate Institutional Review Board. Informed consent was obtained from focus group participants; written consent was waived.
: Not applicable.
: Dr. Byatt has served on advisory boards for Sage Therapeutics and as a speaker for Sage Therapeutics. She has served as a consultant for Sage Therapeutics and Ovia Health and has received honoraria from Miller Medical Communications and WebMD/Medscape. Dr. Byatt is also the statewide Medical Director of the Massachusetts Child Psychiatry Access Program (MCPAP) for Moms and thus has received salary and/or funding support from the Massachusetts Department of Mental Health.